At Nanobubble Insights Ltd, we specialise in delivering tailored advisory services for businesses looking to enhance efficiency and sustainability through the cutting-edge application of nanobubble technology. With expertise built on over five years of leadership in nanobubble research and development, our mission is to revolutionise industries by combining innovative solutions with environmental stewardship. Nanobubbles are microscopic gas bubbles with unique properties that improve oxygenation, enhance water quality, and optimise resource use. This breakthrough technology has applications across a wide range of industries, including agriculture, water treatment, aquaculture, and industrial processes. Whether it's reducing chemical usage, improving crop yields, or creating healthier aquatic environments, we provide customised strategies that align with our clients’ operational and sustainability goals.

Healthcare provision is under ever greater pressure from simultaneous financial and health challenges. Added to this there are still many unmet needs for the diagnosis, prognosis, treatment and monitoring of disease. The Centre for Medical Engineering and Technology brings Engineers, Physicists, and Life Scientists together with Clinicians to solve some of the most pressing challenges in healthcare.

Our research is challenge led, developing solutions to address real clinical needs whilst maintaining the link to the science and engineering developments that will provide the solutions of the future.

Healthcare of the future faces many challenges that include changing population dynamics, public expectations, need for improved delivery of care, early diagnostics and economic austerity.

By bridging the gap between engineering and medicine, Biomedical Engineers and Technologists are best equipped to combine a diverse set of skills to create solutions to continuing worldwide health issues, helping to change how patients are treated and lowering the cost of care, and transforming people’s lives for the better.

Platinum Discovery offers a cutting-edge Tumour-to-Target Platform, specialising in cancer vaccine development through the identification of tumour-specific neoantigens. We are pioneering advancements in neoantigen discovery, laying the groundwork for the next generation of cancer vaccines.